Daniel Hart, PhD, the senior director and head of technology development at Epic Bio, discussed potential applications of the new technology.
Google Alert – Hart
Daniel Hart, PhD, on CRISPR-Mediated In Vivo Epigenomic Activation – CGTLive®
CGTLive spoke with Hart to learn more about the findings and their significance in the field. He shared further research that Epic is conducting with …
Google Alert – Hart
Evaluation of Daily CT for EPID-Based Transit In Vivo Dosimetry – Docwire News
Front Oncol. 2021 Nov 2;11:782263. doi: 10.3389/fonc.2021.782263. eCollection 2021.ABSTRACTPURPOSE: The difference in anatomical structure and …
Google Alert – Transit